Preview

Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)

Advanced search
Open Access Open Access  Restricted Access Subscription or Fee Access

Evaluation of the effectiveness of probiotic bacteria Bifidobacterium BB-12 and Streptococcus thermophilus TH-4 in the prevention of microecological and gastrointestinal disorders in children born by cesarean section

https://doi.org/10.21508/1027-4065-2024-69-5-45-51

Abstract

The clinical and laboratory effectiveness of a biocomplex of probiotic bacteria (Bifidobacterium BB-12, Streptococcus thermophilus TH-4) in preventing the development of microecological and gastrointestinal disorders in children born by cesarean section has been studied. A prospective open comparative study was conducted. The main group consisted of 16 healthy newborns born by cesarean section who were treated with a probiotic (Bifidobacterium BB-12, Streptococcus thermophilus TH-4) at 1 dose once a day. Oral administration of the probiotics began immediately after delivery and continued for 14 days. A control group of 21 healthy babies born by caesarian section who did not receive the probiotics during the study period was also included. Bacteriological analysis of fecal samples and assessment of the health status were performed at the ages of 4–5 days, 1 month, and 3 months. In children receiving probiotics, the incidence of infantile intestinal colic was lower at the age of 1 month, opportunistic microflora were less frequently isolated (p<0.01), and signs of inflammation in the intestines were less often detected during the follow-up period, as shown by a coprological study.

Conclusion. The effectiveness of using probiotics (Bifidobacterium BB-12 and S. thermophilus TH-4) to prevent microecological and gastrointestinal problems in children born by cesarean section has been demonstrated.

About the Authors

I. V. Nikolaeva
Kazan State Medical University of the Ministry of Health of Russia
Russian Federation

Kazan



G. S. Shaikhieva
Republican Clinical Hospital of Infectious Diseases
Russian Federation

Kazan



L. R. Gaynatullina
Republican Clinical Hospital of Infectious Diseases
Russian Federation

Kazan



References

1. Derrien M., Alvarez A.S., de Vos W.M. The gut microbiota in the first decade of life. Trends Microbiol 2019; 27(12): 997–1010. DOI: 10.1016/j.tim.2019.08.001

2. Papathoma E., Triga M., Fouzas S., Dimitriou G. Cesarean section delivery and development of food allergy and atopic dermatitis in early childhood. Pediatr Allergy Immunol 2016; 27(4): 419–424. DOI: 10.1111/pai.12552

3. Francino M.P. Birth mode-related differences in gut microbiota colonization and immune system development. Ann Nutr Metab 2018; 73(Suppl 3): 12–16. DOI: 10.1159/000490842

4. Li N., Liang S., Chen Q., Zhao L., Li B., Huo G. Distinct gut microbiota and metabolite profiles induced by delivery mode in healthy Chinese infants. J Proteomics 2021; 232: 104071. DOI: 10.1016/j.jprot.2020.104071

5. Dogra S., Sakwinska O., Soh S. E., Ngom-Bru C., Brück W.M., Berger B. et al. Dynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity. MBio 2015; 6 (1): E02419–14. DOI: 10.1128/mBio.02419–14

6. Nikolaeva I.V. Formation of intestinal microflora and factors influencing this process. Detskie infektsii 2011; 10 (3): 39–42. (in Russ.)

7. Navarro-Tapia E., Sebastiani G., Sailer S., Toledano LA., Serra-Delgado M., García-Algar Ó. et al. Probiotic Supplementation During the Perinatal and Infant Period: Effects on Gut Dysbiosis and Disease. Nutrients 2020;12(8):2243. DOI: 10.3390/nu12082243

8. Nikolaeva I.V., Anohin V.A., Kupchihina L.A., Haliullina S.V. Risk of infectious and somatic diseases in infants born by cesarean section. Prakticheskaya meditsina 2013; 6 (75): 93–96. (in Russ.)

9. Nikolaeva I.V., Shajhieva G.S., Haertynov H.S., Gataullin M.R., Urmancheeva Yu.R. Etiological structure and features of clinical manifestations of neonatal infections in children born by cesarean section. Rossiyskiy vestnik perinatologii i pediatrii 2017; 62(5): 88–92. (in Russ.) DOI:10.21508/1027–4065–2017–62–5–88–92

10. Gong Y., Zhong H., Wang J., Wang X., Huang L., Zou Y. et al. Effect of probiotic supplementation on the gut microbiota composition of infants delivered by cesarean section: an exploratory, randomized, open-label, parallel-controlled Trial. Curr Microbiol 2023; 80 (11): 341. DOI: 10.1007/s00284–023–03444–4

11. Korpela K., Salonen A., Vepsäläinen O., Suomalainen M., Kolmeder C., Varjosalo M. et al. Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants. Microbiome 2018; 6(1): 182. DOI: 10.1186/s40168–018–0567–4

12. Ahmadi E., Alizadeh-Navaei R., Sadegh Rezai M. Efficacy of probiotic use in acute rotavirus diarrhea in children: A systematic review and meta-analysis. Caspian J Intern Med 2015; 6(4): 187–195.

13. Guandalini S., Cernat E., Moscoso D. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. Benef Microbes 2015; 6(2): 209–217. DOI: 10.3920/BM2014.0067

14. Blaabjerg S., Artzi D.M., Aabenhus R. Probiotics for the prevention of antibiotic-associated diarrhea in outpatients — a systematic review and meta-analysis. Antibiotics (Basel) 2017; 6(4): 21. DOI: 10.3390/antibiotics6040021

15. Ruzhencova T.A., Havkina D.A., Ploskireva A.A., Meshkova N.A. Childhood functional gastrointestinal disorders: rational therapy. Medicinskij Sovet 2020; 1: 106–112. (in Russ.) DOI: 10.21518/2079–701X-2020–1–106–112

16. Robertson C., Savva G.M., Clapuci R., Jones J., Maimouni H., Brown E. et al. Incidence of necrotising enterocolitis before and after introducing routine prophylactic Lactobacillus and Bifidobacterium probiotics. Arch Dis Child Fetal Neonatal Ed 2020; 105: 380–386. DOI: 10.1136/archdis-child-2019–317346

17. Shirazinia R., Golabchifar A.A., Fazeli M.R. Efficacy of probiotics for managing infantile colic due to their anti-inflammatory properties: a meta-analysis and systematic review. Clin Exp Pediatr 2021; 64(12): 642–651. DOI: 10.3345/cep.2020.01676

18. Mazankova L.N., Rybal’chenko O.V., Kornienko E.A., Perlovskaja S.G. Probiotics in pediatrics: pros and cons in the context of evidence-based medicine. Rossiyskiy vestnik perinatologii i pediatrii 2016; 1: 16–26. (in Russ.) DOI: 10.21508/1027–4065–2016–61–1–17–23

19. Andreeva I.V., Stecjuk O.U. Efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium lactis BB-12 combination in gastroenterology, pediatrics and allergology. Klinicheskaya mikrobiologiya i antimikrobnaya himioterapiya 2016; 2(18): 113–124. (in Russ.)

20. Jungersen M., Wind A., Johansen E., Christensen J.E., Stuer-Lauridsen B., Eskesen D. The Science behind the Probiotic Strain Bifidobacterium animalis subsp. Lactis BB-12. Microorganisms 2014; 2: 92–110. DOI: 10.3390/microor-ganisms2020092

21. Sharma R., Bhaskar B., Sanodiya B.S., Thakur G.S., Jaiswal P., Yadav N. et al. Probiotic Efficacy and Potential of Streptococcus thermophilus modulating human health: A synoptic review. J Pharm Biol Scie 2014; 9(3): 52–58. DOI: 10.9790/3008–09325258

22. Patel S., Chaudhari M., Kadam S., Rao S., Patole S. Standardized feeding and probiotic supplementation for reducing necrotizing enterocolitis in preterm infants in a resource limited set up. Eur J Clin Nutr 2018; 72: 281–287. DOI: 10.1038/s41430–017–0040–7

23. Plummer E.L., Bulach D.M., Murray G.L., Jacobs S.E., Tabrizi S.N., Garland S.M. Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial. BMC Microbiol 2018; 18(1): 184. DOI: 10.1186/s12866–018–1326–1

24. Pahomovskaja N.L., Venediktova M.M. Impact of early-life microbiota on the development of infants. Meditsinskii sovet 2018; 2: 200–205. (in Russ.) DOI: 10.21518/2079–701X-2018–2–200–205

25. Mazankova L.N., Jakovleva G.Yu., Ardatskaja M.D. Rotavirus infection in infant: rationale of probiotics therapy. Detskie infektsii 2011; 2: 52–56. (in Russ.)


Review

For citations:


Nikolaeva I.V., Shaikhieva G.S., Gaynatullina L.R. Evaluation of the effectiveness of probiotic bacteria Bifidobacterium BB-12 and Streptococcus thermophilus TH-4 in the prevention of microecological and gastrointestinal disorders in children born by cesarean section. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2024;69(5):45-51. (In Russ.) https://doi.org/10.21508/1027-4065-2024-69-5-45-51

Views: 277


ISSN 1027-4065 (Print)
ISSN 2500-2228 (Online)